SP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63757896132211E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.2667644710973E-13 |
Normal-vs-Stage2 |
5.87479953573222E-10 |
Normal-vs-Stage3 |
3.20850013224572E-11 |
Normal-vs-Stage4 |
9.06679997747517E-09 |
Stage1-vs-Stage2 |
9.657000E-01 |
Stage1-vs-Stage3 |
7.837200E-01 |
Stage1-vs-Stage4 |
2.953400E-01 |
Stage2-vs-Stage3 |
7.934600E-01 |
Stage2-vs-Stage4 |
3.887400E-01 |
Stage3-vs-Stage4 |
5.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.05735428693288E-12 |
Normal-vs-AfricanAmerican |
2.22044604925031E-16 |
Normal-vs-Asian |
2.42470000000328E-06 |
Caucasian-vs-AfricanAmerican |
1.291980E-01 |
Caucasian-vs-Asian |
5.560200E-01 |
AfricanAmerican-vs-Asian |
8.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
3.4347000021917E-08 |
Male-vs-Female |
1.048480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.62500079637607E-11 |
Normal-vs-Extreme_Weight |
2.17748041819732E-12 |
Normal-vs-Obese |
4.65183447317941E-14 |
Normal-vs-Extreme_Obese |
7.88120002592763E-09 |
Normal_Weight-vs-Extreme_Weight |
8.404600E-01 |
Normal_Weight-vs-Obese |
5.210600E-01 |
Normal_Weight-vs-Extreme_Obese |
5.671400E-01 |
Extreme_Weight-vs-Obese |
6.398400E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.216000E-01 |
Obese-vs-Extreme_Obese |
2.268200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.03209999990916E-07 |
Normal-vs-Age(41-60Yrs) |
1.35219613284221E-11 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
4.49210002528844E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.156600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.833400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.348800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.587900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.420390E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.241600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62592161956354E-12 |
Normal-VS-Type2 PRCC |
<1E-12 |
Normal-VS-KIRP CIMP |
4.27499999999803E-05 |
Normal-VS-Unclassified PRCC |
1.87549999974834E-07 |
Type1 PRCC-VS-Type2 PRCC |
4.055200E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.977000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.127650E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.442000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.023500E-02 |
KIRP CIMP-VS-Unclassified PRCC |
8.287000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62525548574877E-12 |
Normal-vs-N1 |
1.93899996059343E-09 |
Normal-vs-N2 |
1.9856099999993E-05 |
N0-vs-N1 |
8.535800E-02 |
N0-vs-N2 |
5.749600E-01 |
N1-vs-N2 |
2.452000E-01 |
|
|